Do you suffer from fear of missing out—also known as FOMO—wondering if other healthcare providers are getting more out of social media websites than you?
Could you get a better job if you networked on LinkedIn? Attract more patients by promoting your practice on Facebook? Be the first person to know about drug recalls that affect your patients from Twitter?
Oncology Nurse Advisor’s Social Media Survey attempts to answer those questions. Overall, 100 nurse practitioners, registered nurses, physicians, and physician assistants responded to our survey in September through October 2014, answering questions about how they used eight well-known social media services: Facebook, Google+, Twitter, YouTube, Pinterest, Instagram, LinkedIn, and Doximity.
Both women and nurse practitioners were overrepresented in our sample, making up 87.88% and 69.63% of respondents, respectively. Just under half of respondents worked in an office practice (42.12%), followed by a hospital (16.62%) or standalone clinic (17.77%), hospitals (16.33%) or walk-in/ambulatory settings (7.16%).
The majority of our sample, nearly 80%, were aged 35 to 64 years, with those aged 35 to 54 years making up 49%, and those aged 55 to 64 years making up 29.8%.
Overall, composite mean platform adoption across the 8 social media sites included in the survey was 45.34% for business purposes and 67.53% for personal use.
Not every participant answered every question. We have indicated total number of respondents for each area addressed. Numbers may not add up to 100% due to rounding.
This is the second installment of Vital Signs, our new crowdsourced feature that aims to bring you easy to absorb visual insights on the latest trends among your clinician peers.
Compiled by Rick Maffei, Senior Digital Content Editor and Nicole Blazek, Senior Clinical Content Editor
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- Patients With Urologic Cancer Need Psycho-oncologic Support to Manage High Stress
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure
- FDA Grants Priority Review to Ceritinib for First-line Treatment of ALK+ NSCLC
- Overall Health Worse in African American Men Undergoing Active Surveillance For Prostate Cancer
- Clinical Benefit of Simtuzumab Inconsistent for Myelofibrosis
- Follow-up Rates in Active Surveillance for Prostate Cancer Higher in University-Based vs Safety-Net Hospitals
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|